T45I (p.Thr45Ile) variant of KRT14 (Keratin, type I cytoskeletal 14)

T45I (p.Thr45Ile) in KRT14 (Keratin, type I cytoskeletal 14) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as likely benign in the context of not provided. The available variant effect predictions contribute to a CATVariant prioritization score of 0.23 / 1. The record also includes population frequency data and structural context.

T45I (p.Thr45Ile) variant details